NCMW
REGN icon

Northern Capital Management (Wisconsin)’s Regeneron Pharmaceuticals REGN Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$908K Sell
2,430
-10
-0.4% -$3.66K 0.24% 120
2018
Q3 		$986K Sell
2,440
-525
-18% -$200K 0.23% 120
2018
Q2 		$1.02M Buy
+2,965
New +$927K 0.25% 121

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s REGN Position: Q4 2018 in Review

Northern Capital Management (Wisconsin) reduced its Regeneron Pharmaceuticals (REGN) stake by 0.41% in Q4 2018, selling an estimated $3.66K and leaving 2,430 shares worth $908K. The position accounts for 0.24% of the portfolio, ranked #120.

Northern Capital Management (Wisconsin) first reported a position in REGN in Q2 2018 and has held it in 3 quarters since. The position peaked at $1.02M in Q2 2018. 671 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

  • Northern Capital Management (Wisconsin) held 2,430 shares of Regeneron Pharmaceuticals worth $908K as of Q4 2018.
  • Northern Capital Management (Wisconsin) sold 10 Regeneron Pharmaceuticals shares in Q4 2018, an estimated $3.66K.
  • Regeneron Pharmaceuticals made up 0.24% of Northern Capital Management (Wisconsin)'s portfolio in Q4 2018, its #120 holding.
  • Northern Capital Management (Wisconsin) first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • Northern Capital Management (Wisconsin)'s Regeneron Pharmaceuticals position peaked at $1.02M in Q2 2018.
  • 671 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2018, filed 1 Feb 2019.